KFP
REGN icon

KB Financial Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

KB Financial Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2K Hold
3
– – ﹤0.01% 536
2023
Q2 		$2K Hold
3
– – ﹤0.01% 558
2023
Q1 		$2K Hold
3
– – ﹤0.01% 545
2022
Q4 		$2K Hold
3
– – ﹤0.01% 543
2022
Q3 		$2K Hold
3
– – ﹤0.01% 529
2022
Q2 		$2K Hold
3
– – ﹤0.01% 541
2022
Q1 		$2K Hold
3
– – ﹤0.01% 577
2021
Q4 		$2K Buy
+3
New +$1.84K ﹤0.01% 608
2021
Q3 		– Sell
-3
Closed -$2K – 482
2021
Q2 		$2K Hold
3
– – ﹤0.01% 585
2021
Q1 		$1K Buy
+3
New +$1.46K ﹤0.01% 619

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KB Financial Partners's REGN Position: Q3 2023 in Review

KB Financial Partners held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2023 at 3 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

KB Financial Partners first reported a position in REGN in Q1 2021 and has held it in 10 quarters since. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • KB Financial Partners held 3 shares of Regeneron Pharmaceuticals worth $2K as of Q3 2023.
  • KB Financial Partners left its Regeneron Pharmaceuticals share count unchanged in Q3 2023.
  • Regeneron Pharmaceuticals made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #536 holding.
  • KB Financial Partners first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
  • 1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.